Member Info for Fredd1eboy

I refer the David's recent presentation to a distinguished audience, as a guest and by invitation from his Chinese colleagues...wouldn't it be nice to see something emerging which leads to an expansion of Aptamers network of business. Now that would be great news as far as I'm concerned.

If I was a strategist in either of the two camps, I'd be looking at buying out/taking over clear UK gems.....I'd place aptamer firmly in that category. Watch this space......We could very well sky rocket earlier than we could have expected.

Watch this space as I'd love to say.....I told you so!

Too true GG.....We have to accept the dip today is due to global issues...As far as Apta is concerned we will recover on quantifiable news and my guess is that its not far away...Just needs us to hold our resolve and continue to top up during these dips

.....we all catch a cold......well hopefully not us as, thank goodness, we should be off the 'US jobs' radar.... Good old Trump....I don't think!

My sentiments too ME....In my opinion we remain, even stronger, a 100 % buy...

'We can only blame Trump'.

Perhaps UK Gov have to accept some of the blame?

FAO any in academia who post on this site and have access to UKGOV.

With the Trump visit due next week, is there any chance of lobbying UKGOV and adding this to the agenda for discussion. Its clearly a major setback to UK pharma and those who depend on it.

Merk......In canceling UK pharma investment .....another 1000 jobs that won't go ahead.

We can only blame Trump.

Thank goodness our contracts with both are unaffected, albeit its a set back for UK pharma generally.

I forgot to add...they have invested, and between them all have significant stock holdings...

Hi Olearney.....Under any other circumstances I too would be concerned regarding the ability of a busy company efficiently handling an increasing workload.

However, we shareholders are fortunate to have talented professionals running Aptamer ie. Doctors ..Adam Hargreaves, Arron Tolley, David Bunka supported by Andrew Rapson, a dedicated scientific and administrative team.....together with a team of advisor's.....

So I'm happy to let them get on with it, as I'm sure they will continue to keep us updated on progress.....I believe my not too insignificant investment is safe and will grow in their hands...Especially once the irritation of top slicing eases off

Signal Update

Today's recommendation from our system is to STAY LONG. The previous BUY signal was issued on 08/09/2025, 3 days ago, when the stock price was 1.0250. Since then, APTA.L has risen by +7.32%.

Market Outlook

The market is currently exhibiting uncertainty with a negative bias. There seems to be a lack of consensus among traders. The negative sentiment, however, is increasing, as evident from the latest bearish pattern. Therefore, it's wise to stay vigilant. The share price is still not below the confirmation level and the signal is suggesting to STAY LONG, but the chance of a bearish confirmation that will change the signal to

....RNS release was as a consequence of responding to the Metir RNS......under any other circumstances it would have been released along with updates on several orders... Eitherway great news for both Aptamer and Metir... A 'marriage made in heaven'.

Https://www.lse.co.uk/CompanyTimeline.html?shareprice=APTA&share=Aptamer-Group

Sounds a great plan ME....I'm currently grieving the sale of my Rival 38, looking for a smoky.....Your'e making me green with envy. Good luck my friend....

Where do you fancy moving to...ME

Doesn't do our sp any favours but at least helps to explain why latest RNS has fallen flat.......As far as Im concerned it only as to our stable foundation.....and, in time, will probably be reflected later.

UK Gov not supporting pharma.

Come on Labour and get your act together

For info

https://www.ft.com/content/5ace49a8-47ab-409d-8909-6edb107ce71a

Ps level 2 is currently not reflecting reality.

My guess is that all will be revealed at end of play when the impact of top slicing is revealed. In the interim, guess we just have to remain content with crumbs dropping from the top table. Key is don't get despondent, if you can just keep topping up...I've a wallet bulging at the seams of the little

buggers, awaiting the issue of quantifiable data. Then boom....were off!